Dr Edwin Wagena

Ed is an experienced hands-on senior executive, trained as epidemiologist with a PhD in Medicine, with more than 20 years of experience in drug development. Since 2008, Ed specialised in the development of ATMPs and orphan drugs. He has designed and managed the European and North-American regulatory strategy and development program for several innovative therapies, including late-stage (pivotal) clinical trials.

An innovative solution for storing and transporting cells and tissues at room temperature.